Kirk G. Nielsen - 02 Jul 2021 Form 4 Insider Report for CVRx, Inc. (CVRX)

Role
Director
Signature
/s/ Amy C. Seidel, Attorney-in-Fact
Issuer symbol
CVRX
Transactions as of
02 Jul 2021
Net transactions value
$0
Form type
4
Filing time
02 Jul 2021, 17:03:02 UTC
Previous filing
01 Jul 2021
Next filing
23 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVRX Common Stock Conversion of derivative security +1,461,831 1,461,831 02 Jul 2021 See Footnote F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVRX Series G Preferred Stock Conversion of derivative security $0 -23,125,000 -100% $0.000000* 0 02 Jul 2021 Common Stock 1,461,831 See Footnote F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Upon the closing of the Issuer's initial public offering, each share of Series G Convertible Preferred Stock automatically converted into shares of common stock at a rate of 1-for-0.0632143218.
F2 These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.
F3 Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of common stock at the then-appliable conversion rate for no additional consideration (subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the common stock.